Neuronetics (STIM) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts STIM Hot Sheet
Join SI Premium – FREE
Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $41.57 million versus the consensus estimate of $40.11 million.
For earnings history and earnings-related data on Neuronetics (STIM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 24c
- Reborn Coffee signs non-binding MOU to enter U.S. produce supply
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
